A novel targeted GPC3/CD3 bispecific antibody for the treatment hepatocellular carcinoma-Reference-Cited by-同舟云学术

A novel targeted GPC3/CD3 bispecific antibody for the treatment hepatocellular carcinoma

Published:2020-04-02 Issue:7 Volume:21 Page:597-603
ISSN:1538-4047
Container-title:Cancer Biology & Therapy
language:en
Short-container-title:Cancer Biology & Therapy

Author:

Yu Lin¹,Yang Xi²³⁴⁵,Huang Nan²³⁴⁵,Lang Qiao-Li²³⁴⁵,He Qi-Lin²³⁴⁵,Jian-Hua Wang¹,Liang-Peng Ge²³⁴⁵

Affiliation:

1. Key Laboratory of Biorheological Science and Technology (Ministry of Education), College of Bioengineering, Chongqing University, Chongqing, China

2. Department of Bioengineering, Chongqing Academy of Animal Sciences, Chongqing, China

3. Key Laboratory of Pig Industry Sciences, Ministry of Agriculture, Chongqing, China

4. Department of Bioengineering, Chongqing Key Laboratory of Pig Industry Sciences, Chongqing, China

5. Department of Bioengineering, Chongqing Engineering Technology Research Center for Medical Animal Resources Development and Application, Chongqing, China

Funder

National Major Scientific Research Instrument Development Project of NSFC

The Key R & D Project in Agriculture and Animal Husbandrys of Rongchang

Publisher

Informa UK Limited

Subject

Cancer Research,Pharmacology,Oncology,Molecular Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/15384047.2020.1743158

Reference33 articles.

1. Hepatocellular carcinoma

2. Developments in therapy with monoclonal antibodies and related proteins

3. Imaging the expression of glypican-3 in hepatocellular carcinoma by PET

4. Glypican-3: A promising biomarker for hepatocellular carcinoma diagnosis and treatment

5. Anti–Glypican 3 Antibody as a Potential Antitumor Agent for Human Liver Cancer

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunotherapy for hepatocellular carcinoma;JHEP Reports;2024-10

2. Role of immunotherapies and stem cell therapy in the management of liver cancer: A comprehensive review;International Immunopharmacology;2024-05

3. Computational discovery of co-expressed antigens as dual targeting candidates for cancer therapy through bulk, single-cell, and spatial transcriptomics;Bioinformatics Advances;2024

4. A Transformable Supramolecular Bispecific Cell Engager for Augmenting Natural Killer and T Cell‐Based Cancer Immunotherapy;Advanced Materials;2023-12

5. Targeting the interactions between lymphocytes and liver cancer stem cells in combination with immunotherapy is a promising therapeutic strategy;Hepatoma Research;2023